Table 4. Univariate Logistic Regression Analysis to Identify the Risk Factors for Early-Onset VIPN .
Factor | Odds ratio | 95% CI | P value |
---|---|---|---|
Male | 0.38 | 0.10 - 1.45 | 0.16 |
Age | 0.92 | 0.86 - 0.98 | 0.013* |
Body weight | 0.97 | 0.91 - 1.03 | 0.31 |
Aspartate aminotransferase | 1.01 | 0.96 - 1.07 | 0.59 |
Alanine aminotransferase | 1.05 | 0.98 - 1.12 | 0.14 |
γ-glutamyltranspeptidase | 1.00 | 0.98 - 1.03 | 0.56 |
Total bilirubin | 3.41 | 0.25 - 47.00 | 0.36 |
Creatinine clearance | 1.01 | 0.99 - 1.03 | 0.21 |
Diabetes mellitus requiring medication | 0.44 | 0.045 - 4.39 | 0.49 |
Lymphoma type | |||
Diffuse large B-cell lymphoma | 1.44 | 0.38 - 5.45 | 0.59 |
Follicular lymphoma | 0.48 | 0.085 - 2.68 | 0.40 |
Others | 1.20 | 0.24 - 5.97 | 0.80 |
VCR dose | 40.81 | 1.09 - 1,524.04 | 0.045* |
Concomitant use of aprepitant | 5.00 | 1.22 - 20.46 | 0.025* |
*Included in the multivariate logistic regression analysis.